Last term, Drexel University faculty members were recognized for their scholarly research and prolific academic and professional contributions. This update offers a snapshot of activity courtesy of ...
Actively enrolling Cohort 3 (FTD-GRN) and Cohort 4 (FTD-C9orf72) patients in ongoing upliFT-D study Aligned with the U.S. Food and Drug Administration (FDA) on an analytical approach to establish ...
CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $524 million EC and U.S. FDA label updates for CARVYKTI ® to include overall survival benefit versus standard of care ...
Aimco to Seek Shareholder Approval to Adopt Plan of Sale and Liquidation, Estimates Liquidating Distributions of Between $5.75 and $7.10 Per Share. DENVER, Nov. 10, 2025 /PRNewswire/ -- Apartment ...
View source version on businesswire.com: https://www.businesswire.com/news/home/20251106177990/en/ The articles, information, and content displayed on this webpage ...
Follow tonight's NBA action with the latest highlights and happenings around the league. NBA.com Staff MILWAUKEE, WI – NOVEMBER 20: Tyrese Maxey #0 of the Philadelphia 76ers drives to the basket ...
The Indianapolis Colts defeated the Atlanta Falcons in a 31-25 win to kick off Week 10 from Olympiastadion in Berlin. In the early window, the Ravens stayed hot with a 27-19 win over the Vikings and ...
- Closed registered direct offering for aggregate gross proceeds of US$175 million (the “Registered Direct Offering”) led by a syndicate of prominent biopharmaceutical institutional investors - - On ...
BOISE, Idaho, Nov. 17, 2025 /PRNewswire/ - Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) ("Perpetua Resources" or "Perpetua" or the "Company") announced today that its unaudited condensed ...
Completed enrollment in Phase 3 IMpactMF clinical trial evaluating imetelstat in relapsed/refractory myelofibrosis Strengthened leadership team with appointment of Chief Commercial Officer and ...
PEMGARDA® (pemivibart) net product revenue of $13.1 million reported for Q3 2025, representing 41% growth year-over-year and 11% growth quarter-over-quarter October 2025 ending cash and cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback